November 16th, 2016
Tackling blood diseases and immune disorders
Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Startups
September 28th, 2016
Wyss Institute launches ReadCoor to commercialize 3D in situ gene sequencing technology
New startup will leverage a method for simultaneously sequencing and mapping thousands of RNAs within cells and tissues to advance development of diagnostics and discover new drug targets
August 4th, 2016
Harvard spinout Validere to commercialize ‘liquid fingerprinting’ technique
Ability to instantly identify unknown liquids in the field could aid first responders, improve plant safety
May 18th, 2016
Harvard licenses genotyping platform to startup Aldatu Biosciences
Novel qPCR platform enables development of drug resistance testing products for HIV
April 4th, 2016
Our blood, ourselves
Two Harvard-trained researchers, who bonded while battling epidemics in West Africa, are developing diagnostic technology to help women monitor their own health and fertility.
